Botulinum toxin for achalasia: long-term outcome and predictors of response.
about
Classification of oesophageal motility abnormalitiesTreatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment.Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trialClinical management of achalasia: current state of the artData analyses and perspectives on laparoscopic surgery for esophageal achalasiaIdiopathic (primary) achalasia: a reviewRecent trends in endoscopic management of achalasiaUpdate on the endoscopic treatments for achalasia.Management of primary achalasia: The role of endoscopyAchalasia: outcome of patients treated with intrasphincteric injection of botulinum toxinA controversy that has been tough to swallow: is the treatment of achalasia now digested?Review article: pharmacological options in achalasia.Achalasia: current therapeutic optionsEsophageal pharmacology and treatment of primary motility disorders.Achalasia: a new clinically relevant classification by high-resolution manometryAchalasia - an update.Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.Current approach to the treatment of achalasia.The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders.Endoscopic approaches to treatment of achalasiaOesophageal surgeryReview article: the management of achalasia - a comparison of different treatment modalities.Idiopathic (primary) achalasia.Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trialA multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.The aging oesophagus.Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in JapanAchalasia of the cardia: dilatation or division? The case for balloon dilatationBotulinum toxin for gastrointestinal disorders: therapy and mechanisms.Endoscopic approach to achalasia.Update on the management of achalasia: balloons, surgery and drugs.Epidemiology and practice patterns of achalasia in a large multi-centre database.Surgical treatment for achalasia: when should it be performed, and for which patients?ACG clinical guideline: diagnosis and management of achalasia.Distal esophageal spasm: an update.Management strategies for achalasia.An update on the use of botulinum toxin therapy in Parkinson's disease.Treatment of gastrointestinal sphincters spasms with botulinum toxin A.Treatments for achalasia in 2017: how to choose among them.
P2860
Q24669727-8F650121-B76E-4FF3-889C-6D02C12ECBC6Q24799447-3BD36057-1CC0-4BB4-B857-DD5A15645986Q24806135-4CB2ECCD-BE44-4B96-9000-0C67C7FA6AD8Q26750707-B5F9B066-44EE-4CC0-8479-0860AB569013Q26781982-53117D6A-E97B-48AD-A08F-36C7A46D2DFCQ26801313-A8778AE4-EC2E-4711-8626-EA19C5C2C2C0Q26865445-CDE68861-949C-4E95-8410-0285B7F1A63DQ28075534-F0390570-D983-4EE8-81D8-FAF1FCEAEEA8Q28083770-A86F3D15-B43A-4E94-8127-C11F99B77B25Q33618302-35607171-1921-42A0-9F20-76DD57C01709Q33672723-4518D00F-BE98-4426-9876-FE8CAB88E36BQ33778807-95239612-8CEC-410F-8C28-C7BDDF894CD2Q33887695-0723AF79-7D2B-453A-91BA-852F2C6998B4Q33894383-590DFE00-0E4A-4F5C-9556-4F912D7E1AEBQ33952505-6C8E980D-14AC-4F1B-B2E2-6350E51F3E1AQ34028403-E5990ACC-2557-445C-8E69-AF41631E6367Q34041378-13916D9F-3CC4-45FC-B2C8-3BCB575A9916Q34172430-75529BDA-6287-4869-8799-7D1B3BEE0257Q34291154-60D5D8BE-6B6D-4F3A-97BE-8D39DF905F67Q34333494-62F74E2B-6116-4F88-8B98-547DD711DF7EQ34538207-ACA4BE0A-BFB0-4C3F-AADD-095168988879Q34562734-B775381B-1582-45CC-B46B-515876B3EE27Q34583301-BCEEEC9F-1BB1-49DB-82ED-AA35E2149444Q34978565-F62259F6-498A-401C-9CDA-884109552DD9Q35354031-22610043-039C-4591-B285-DB880EE02B9DQ35360275-48B90CA9-F344-4F94-A18F-E91509AA4FBAQ35841129-497BBADC-A4B9-4F67-A588-3956A5BF119CQ36265364-81CBAF09-273B-4C7B-BA99-FC0FAC0D51E1Q36388032-C4F85DA5-5E9F-4BD7-ACDD-EEBB34127DFEQ36511599-759B9CD5-9FB0-46C1-B7DF-2C48165A949DQ37093306-DBADEDF4-33E1-4E5C-9458-CCB03814A8BFQ37345954-3D4E580C-A9C5-47A5-83B8-547D37CFDFE2Q37380285-DE74BA38-951A-44E1-8EFE-D547EE522B7CQ37889738-E7F1010C-C1C0-47EB-9266-F71FFA400D25Q38123364-8BC9BB7E-FDEE-423C-855A-6BD2CA937FBDQ38124718-F2D5C73E-2CAE-4AFE-B473-D3BB9B14A4B1Q38244263-63BBB4FA-DC0B-475E-BE93-D25706C96218Q38269292-4DFED06F-339B-4414-8598-263AAFF45572Q38512950-8F6241D9-FCDC-4936-8830-7E127BCD5C09Q38828675-C1A6ECFA-3460-414B-9440-65E298DCF191
P2860
Botulinum toxin for achalasia: long-term outcome and predictors of response.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@en
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@nl
type
label
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@en
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@nl
prefLabel
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@en
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@nl
P2093
P1433
P1476
Botulinum toxin for achalasia: long-term outcome and predictors of response.
@en
P2093
P304
P356
10.1053/GAST.1996.V110.PM8613045
P407
P577
1996-05-01T00:00:00Z